Appraisal Of The Integrity Of Gingival Tissue And Crestal Bone Of Mandibular Molar Restored With Monolithic Zirconium And PEEK Crowns Supported By Two Different Implant Designs

November 13, 2026 updated by: kareem mohamed mahmoud abdel motaleb

Appraisal Of The Integrity Of Gingival Tissue And Crestal Bone Of Mandibular Molar Restored With Monolithic Zirconium And PEEK Crowns Supported By Two Different Implant Designs (A Controlled Clinical Trial)

Implant-supported prostheses have become a popular treatment option in clinical dentistry because of their long-term clinical success rates and their proven functional, biological, and mechanical advantages.

Dental implants exhibit biomechanical behavior that differs from that of natural teeth because implants lack periodontal ligaments and are in direct contact with bone. Consequently, the occlusal loads received by the implant are transferred directly to the surrounding bone structure. This relationship affects stress distribution within the implant and the peripheral bone and is considered one of the major factors determining implant success. The transfer of stress or energy between the implant and the surrounding bone is influenced by several factors, including the direction of loading and the design and material characteristics of both the implant and the restorative crown.

Soft-tissue attachment around dental implants resembles that around natural teeth, as it includes junctional epithelium and connective tissue fibers. However, some important differences exist. The connective tissue fibers surrounding implants are oriented parallel rather than perpendicular to the implant surface, and the connective tissue around implants is less vascular than that surrounding natural tooth. The formation and maturation of the peri-implant soft-tissue complex require sufficient healing time. Stable soft-tissue attachment is essential for maintaining osseointegration and protecting the underlying peri-implant bone.

Several major factors influence osseointegration, including implant material, implant design, implant surface finish, bone condition, surgical technique, and implant-loading conditions. The first three factors-implant material, macro-design, and micro-surface characteristics-are directly related to the implant itself and may vary according to the manufacturing process.

The macro-design of dental implants may vary considerably, and several aspects of implant geometry can affect treatment outcomes. The implant design should provide adequate primary stability without causing excessive trauma to the osteotomy site, which may result in bone necrosis. It should also contribute to achieving an effective seal at the implant-abutment junction to preserve the integrity of the marginal soft tissues and reduce the risk of mechanical and biological complications. Furthermore, implant design should support the preservation of marginal bone levels during the initial physiological remodeling phase.

Peak horizontal and vertical loading forces are commonly concentrated at the crestal bone level. Therefore, modifications to the implant collar and thread design have been introduced to improve stress distribution and preserve marginal bone. Microthreads at the implant collar, particularly when combined with an internal conical implant-abutment connection, may contribute to improved biomechanical behavior and better maintenance of peri-implant tissues. Surface modifications have also been introduced to enhance osseointegration. These modifications may be achieved chemically by incorporating inorganic or organic components or physically by altering the surface topography at the micrometer or nanometer level.

A dental implant restoration generally consists of three main components: the implant fixture, an abutment that facilitates the support and retention of the restoration, and the final prosthetic restoration. Provisional restorations play an important role in soft-tissue management around implants. A properly finished and polished provisional crown can help establish a healthy peri-implant soft-tissue contour and provide appropriate support for the gingival margin. The decision regarding the timing and type of provisionalization should consider the expected changes in the facial gingival margin and the need to maintain soft-tissue architecture.

Polyetheretherketone is a synthetic thermoplastic polymer characterized by high mechanical performance and has been used as a biomaterial in various medical applications. A modified form of this material, known as BioHPP, has been specifically optimized for dental applications. It is reinforced with ceramic fillers to improve its mechanical properties and make it suitable for the fabrication of crowns and fixed prostheses.

Monolithic zirconia restorations represent another treatment option. These restorations are milled from solid zirconia blocks and may be individually stained to reproduce the appearance of enamel and gingival tissues. Zirconia provides favorable esthetic properties, particularly because it eliminates the dark cervical line that may occur with metal-based restorations. It is also characterized by high strength, durability, wear resistance, and a low risk of chipping or crack formation.

The differences in the elastic modulus, rigidity, and stress-absorbing capacity of PEEK and zirconia may influence the transmission of occlusal forces to dental implants and the surround

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age range of the patients from 35-50 years old
  • Patients able physically and psychologically implant placement
  • patients are medically free.
  • Presence of teeth in opposite arch with normal occlusal relation.
  • Patient with masticatory forces within the normal range
  • Patient with normal muscel tone to avoid bruxer patient and it will be assessed using the electromyograph
  • Supra-gingival margin after preparation.
  • Patients willing to return for follow-up examinations and evaluation.
  • D2 or D3 bone quality will be preferred

Exclusion Criteria:

  • Smoking patients.
  • Patients with poor oral hygiene and motivation.
  • Patients with parafunctional habits.
  • D1 and D4 bone quality will be excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: first implant design

first implant design

PEEK crown

zirconia crown

Experimental: second implant design

second implant design

PEEK crown

zirconia crown

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
crestal bone loss
Time Frame: 1 year

Intraoral X-rays will be made using the long-cone parallel technique for the two groups. All radiographs were digitized for evaluation of the bone levels (BL) at different time points. The marginal BL was determined by measuring the distance between the implant shoulder (reference) and the most coronal bone-to implant contact. These measurements were made by two independent examiners mesially and distally of the implants and in 0.1-mm increments

1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
gingival index
Time Frame: 1 year

Gingival index of the two groups will be assessed by the Loe & Silness gingival index as follow:

Grade 0: (Normal gingival) Natural coral pink gingival. Grade 1: (Mild inflammation) Slight change in color, slight edema. No bleeding on probing.

Grade 2: (Moderate inflammation) Redness, edema and glazing. Bleeding on probing.

Grade 3: (Severe inflammation) Marked redness and edema. Tendency to spontaneous bleeding. Ulceration.

1 year
probing depth
Time Frame: 1 year

Probing pocket depth (PPD) for the two groups will be measured from the mucosal margin to the bottom of the probeable pocket in millimeters with a periodontal probe (PCB 12; Hu-Friedy, Leimen, Germany) at four aspects per implant

mesial distal buccal lingual The subscales will be summed and an average will be taken.

1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • R.M. Kamal et al. / Al-Azhar Journal of Dentistry 11 (2024) 27e31

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Study Registration Dates

First Submitted

November 7, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • serial number of 1006

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe